HISTORY AND CURRENT CONCEPTS IN PERCUTANEOUS HYDROTOMY
Medico-legal practice of hydrotomy
The SIHP organizes training courses throughout the year for:
- Doctors specialising in all disciplines
(general practitioners, rehabilitation specialists, rheumatologists, orthopaedic surgeons, pain specialists, psychiatrists, etc.)
- State-certified nurses practicing in the medico-legal sense only with medical prescription within the context of interventions listed in the French Social Security classification
– For subcutaneous infusions (Hypodermoclysis) AMI 9 or AMI 14, as currently performed in hospitals, institutions, retirement homes, home hospitalisation, or private practice, under medical supervision.
- Healthcare professionals working within their medico-legal remit in the country where they practice.
The SIHP cannot be held liable for illegal practice of medicine.
Organ compliance and plasticity
From a structural and foundational point of view, water creates a veritable intra- and extra-cellular network maintaining the physico-chemical equilibrium (homeostasis).
All organs (liver, heart, lung, kidney, discs, cartilage [typo dans le français: il manque un r], ligaments, tendons, etc.) obey the notion of compliance, which is an indicator of viscosity determined by their water-content.
Compliance = Litre / cm water (Volume / Pressure)
Example: Lung = 0.25 L for 1 cm of water (decreased in case of disease, e.g. fibrosis, emphysema)
Spinal and osteoarticular plasticity directly involve this notion of compliance which determines how they function and their sensitivity (pain).
Example: Discopathy due to disc dehydration or degeneration of cartilage due to joint compression and dessication.
The discs and cartilage have a strong affinity for water (hydrophilia) transforming them into veritable “sponges”. They play the role of shock-absorbers in the joints.
This notion is too often neglected by doctors and orthopaedic surgeons.
Development of therapeutic methods and protocols
Research and observation in a general medical practice over more than 35 years (300 000 medical procedures) allowed the development of therapeutic methods and protocols to resolve the main problems encountered in private practice.
This technique was introduced in the 1980s following studies combining:
– mesotherapy, developed by Dr Michel Pistor.
– hypodermoclysis in geriatric care, oncology, home hospitalisation, etc
– the KLEIN technique, used in cosmetic procedures.
– functional oligotherapy, developed by Dr Picard.
● MESOTHERAPY introduced the concept of local micro-dosed injectable medicine: “Very small amounts, rarely and in the right place” as Dr Pistor recommended as early as 1950. Since 2005, the technique is recognised by the French Academy for medicine and the French National order of physicians. It is now taught in France in several university hospitals (Paris, Lille, Bordeaux, Dijon etc.).
● HYPODERMOCLYSIS consists in the subcutaneous injection of a large amount of solutes associated with drugs, in geriatric care, oncology, nutrition, among others.
This commonly used technique has been the subject of numerous scientific publications.
● The KLEIN TUMESCENT TECHNIQUE has been extensively used in cosmetic medicine, in particular prior to liposuction. It consists in infiltrating the tissues with very dilute Xylocaine-adrenaline and sodium bicarbonate before the introduction of the canules. The infiltration creates a localised “veritable anaesthetic reservoir for delayed release” for the comfort and safety of the patient.
● FUNCTIONAL OLIGO THERAPY was developed by Dr Picard in spa medicine. In his book Vaincre l’Arthrose (Beating Osteoarthritis) published by Rocher, he revealed the concept of bio catalytic nutrition through the use of drinkable and injectable oligo elements (oligosols). It should be remembered that for their functions, cellular physiology and molecular biology mainly use carbon, hydrogen, oxygen, nitrogen and oligo elements to ensure intracellular bio catalysis. Percutaneous hydrotomy could thus constitute the ideal therapeutic method for hydration, nutrition and controlled cellular regeneration in phenomena involving lesions and damage to tissues as a result of disease states (illness).
At the crossroads of these four proven techniques, in our practice over the last decades, the notion of PERCUTANEOUS HYDROTOMY (HPC) emerged for therapeutic ends in chronic or relapsing diseases. It is particularly relevant for applications in general medicine, rheumatology (osteoarthritis), ENT, gastroenterology, cosmetic applications, etc. The therapeutic objective is to use a local reservoir for delayed release with a minimum of side effects, creating a veritable “washout” of the lesion. The concept is of particular interest in degenerative disorders (osteoarthritis, mucosal dysfunction in ENT diseases, gastroenterology, dermatology, etc.)
HPC consists in local deep intradermal injection of highly diluted medical substances to allow better locoregional release, to harness their pharmacological properties, while reducing their side effects as far as possible (“from the drop to the vial”).
Mid-way between traditional allopathic medicine and homeopathy, this method integrates scientifically established pharmacodynamic properties based on studies progressing towards cheaper modern medical techniques. Percutaneous hydrotomy can safely resolve problems linked to the local administration of drugs (pH, viscosity, isotonicity, skin tolerance, tissue resorption, etc.)
In pharmacology, for drugs to act when administered systemically, they must reach their threshold dose, which unfortunately often leads to side-effects which are well known by practitioners. The use of this local technique makes it possible to remain below this threshold dose due to the extensive dilution (mesodilution) and the local application. It makes the provision of micro-dosed products effective, whatever their nature, which would not be possible with systemic treatment.
It nevertheless requires the practitioner to be fully aware of the local properties of the products injected, of any general effects, and in particular of any associations between products. Practitioners must therefore be trained in this technique.
WARNING: Quinton Plasma is not suitable for use in percutaneous hydrotomy because it does not have market authorization (MA) for injection.